世界の自己免疫治療薬市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV10931)
◆英語タイトル:Global Autoimmune Drugs Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV10931
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:93
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは自己免疫治療薬の世界市場について調査・分析した資料です。種類別(関節リウマチ(RA)、多発性硬化症(MS)、乾癬、炎症性腸疾患(IBD)、強直性脊椎炎(AS)、全身性エリテマトーデス(SLE))の市場規模、用途別(病院、在宅医療、専門クリニック)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別自己免疫治療薬の競争状況、市場シェア
・世界の自己免疫治療薬市場:種類別市場規模 2015年-2020年(関節リウマチ(RA)、多発性硬化症(MS)、乾癬、炎症性腸疾患(IBD)、強直性脊椎炎(AS)、全身性エリテマトーデス(SLE))
・世界の自己免疫治療薬市場:種類別市場規模予測 2021年-2026年(関節リウマチ(RA)、多発性硬化症(MS)、乾癬、炎症性腸疾患(IBD)、強直性脊椎炎(AS)、全身性エリテマトーデス(SLE))
・世界の自己免疫治療薬市場:用途別市場規模 2015年-2020年(病院、在宅医療、専門クリニック)
・世界の自己免疫治療薬市場:用途別市場規模予測 2021年-2026年(病院、在宅医療、専門クリニック)
・北米の自己免疫治療薬市場分析:米国、カナダ
・ヨーロッパの自己免疫治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの自己免疫治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の自己免疫治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの自己免疫治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Eli Lilly、GSK、AbbVie、Johnson & Johnson、Biogen、Amgen、Pfizer、Roche、Baxter
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental factors or infections.

Market Analysis and Insights: Global Autoimmune Drugs Market
The global Autoimmune Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Autoimmune Drugs Scope and Market Size
Autoimmune Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Autoimmune Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Eli Lilly
GSK
AbbVie
Johnson & Johnson
Biogen
Amgen
Pfizer
Roche
Baxter

Market segment by Type, the product can be split into
Rheumatoid Arthritis (RA)
Multiple Sclerosis (MS)
Psoriasis
Inflammatory Bowel Disease (IBD)
Ankylosing Spondylitis (AS)
Systemic Lupus Erythematosus (SLE)
Market segment by Application, split into
Hospitals
Homecare Settings
Specialty Clinics

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Autoimmune Drugs Revenue
1.4 Market by Type
1.4.1 Global Autoimmune Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Rheumatoid Arthritis (RA)
1.4.3 Multiple Sclerosis (MS)
1.4.4 Psoriasis
1.4.5 Inflammatory Bowel Disease (IBD)
1.4.6 Ankylosing Spondylitis (AS)
1.4.7 Systemic Lupus Erythematosus (SLE)
1.5 Market by Application
1.5.1 Global Autoimmune Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Homecare Settings
1.5.4 Specialty Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Autoimmune Drugs Market Perspective (2015-2026)
2.2 Global Autoimmune Drugs Growth Trends by Regions
2.2.1 Autoimmune Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Autoimmune Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Autoimmune Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Autoimmune Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Autoimmune Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Drugs Players by Market Size
3.1.1 Global Top Autoimmune Drugs Players by Revenue (2015-2020)
3.1.2 Global Autoimmune Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Autoimmune Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Autoimmune Drugs Market Concentration Ratio
3.2.1 Global Autoimmune Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Autoimmune Drugs Revenue in 2019
3.3 Autoimmune Drugs Key Players Head office and Area Served
3.4 Key Players Autoimmune Drugs Product Solution and Service
3.5 Date of Enter into Autoimmune Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Autoimmune Drugs Historic Market Size by Type (2015-2020)
4.2 Global Autoimmune Drugs Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Autoimmune Drugs Market Size by Application (2015-2020)
5.2 Global Autoimmune Drugs Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Autoimmune Drugs Market Size (2015-2020)
6.2 Autoimmune Drugs Key Players in North America (2019-2020)
6.3 North America Autoimmune Drugs Market Size by Type (2015-2020)
6.4 North America Autoimmune Drugs Market Size by Application (2015-2020)

7 Europe
7.1 Europe Autoimmune Drugs Market Size (2015-2020)
7.2 Autoimmune Drugs Key Players in Europe (2019-2020)
7.3 Europe Autoimmune Drugs Market Size by Type (2015-2020)
7.4 Europe Autoimmune Drugs Market Size by Application (2015-2020)

8 China
8.1 China Autoimmune Drugs Market Size (2015-2020)
8.2 Autoimmune Drugs Key Players in China (2019-2020)
8.3 China Autoimmune Drugs Market Size by Type (2015-2020)
8.4 China Autoimmune Drugs Market Size by Application (2015-2020)

9 Japan
9.1 Japan Autoimmune Drugs Market Size (2015-2020)
9.2 Autoimmune Drugs Key Players in Japan (2019-2020)
9.3 Japan Autoimmune Drugs Market Size by Type (2015-2020)
9.4 Japan Autoimmune Drugs Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Autoimmune Drugs Market Size (2015-2020)
10.2 Autoimmune Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Autoimmune Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Autoimmune Drugs Market Size by Application (2015-2020)

11 India
11.1 India Autoimmune Drugs Market Size (2015-2020)
11.2 Autoimmune Drugs Key Players in India (2019-2020)
11.3 India Autoimmune Drugs Market Size by Type (2015-2020)
11.4 India Autoimmune Drugs Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Autoimmune Drugs Market Size (2015-2020)
12.2 Autoimmune Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Autoimmune Drugs Market Size by Type (2015-2020)
12.4 Central & South America Autoimmune Drugs Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Eli Lilly
13.1.1 Eli Lilly Company Details
13.1.2 Eli Lilly Business Overview
13.1.3 Eli Lilly Autoimmune Drugs Introduction
13.1.4 Eli Lilly Revenue in Autoimmune Drugs Business (2015-2020))
13.1.5 Eli Lilly Recent Development
13.2 GSK
13.2.1 GSK Company Details
13.2.2 GSK Business Overview
13.2.3 GSK Autoimmune Drugs Introduction
13.2.4 GSK Revenue in Autoimmune Drugs Business (2015-2020)
13.2.5 GSK Recent Development
13.3 AbbVie
13.3.1 AbbVie Company Details
13.3.2 AbbVie Business Overview
13.3.3 AbbVie Autoimmune Drugs Introduction
13.3.4 AbbVie Revenue in Autoimmune Drugs Business (2015-2020)
13.3.5 AbbVie Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview
13.4.3 Johnson & Johnson Autoimmune Drugs Introduction
13.4.4 Johnson & Johnson Revenue in Autoimmune Drugs Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 Biogen
13.5.1 Biogen Company Details
13.5.2 Biogen Business Overview
13.5.3 Biogen Autoimmune Drugs Introduction
13.5.4 Biogen Revenue in Autoimmune Drugs Business (2015-2020)
13.5.5 Biogen Recent Development
13.6 Amgen
13.6.1 Amgen Company Details
13.6.2 Amgen Business Overview
13.6.3 Amgen Autoimmune Drugs Introduction
13.6.4 Amgen Revenue in Autoimmune Drugs Business (2015-2020)
13.6.5 Amgen Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Autoimmune Drugs Introduction
13.7.4 Pfizer Revenue in Autoimmune Drugs Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Roche
13.8.1 Roche Company Details
13.8.2 Roche Business Overview
13.8.3 Roche Autoimmune Drugs Introduction
13.8.4 Roche Revenue in Autoimmune Drugs Business (2015-2020)
13.8.5 Roche Recent Development
13.9 Baxter
13.9.1 Baxter Company Details
13.9.2 Baxter Business Overview
13.9.3 Baxter Autoimmune Drugs Introduction
13.9.4 Baxter Revenue in Autoimmune Drugs Business (2015-2020)
13.9.5 Baxter Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Eli Lilly、GSK、AbbVie、Johnson & Johnson、Biogen、Amgen、Pfizer、Roche、Baxter

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の自己免疫治療薬市場2026:インサイト・予測(Global Autoimmune Drugs Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。